Clinical Trial Update: Autologous Cytomegalovirus (CMV)-Specific Cytotoxic T Cells for Cytomegalovirus (CMV) Reactivation [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating autologous CMV-specific cytotoxic T cells for CMV reactivation in leukemia and lymphoma patients has completed with results posted in 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Lymphoma

Drugs mentioned

• Autologous CMV-specific cytotoxic T cells (CMV-specific cytotoxic T cells)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Leukemia, Lymphoma | Phase 2 | Status: COMPLETED | Results posted: 2020-03-17